首页> 外文会议>第二届全国分子模拟与信息技术软件应用研讨会暨第四届创腾科技用户大会 >Modeling of p38 mitogen-activated protein kinase inhibitors using the Catalyst™ HypoGen and k-nearest neighbor QSAR methods
【24h】

Modeling of p38 mitogen-activated protein kinase inhibitors using the Catalyst™ HypoGen and k-nearest neighbor QSAR methods

机译:使用Catalyst™HypoGen和k近邻QSAR方法对p38丝裂原活化的蛋白激酶抑制剂进行建模

获取原文

摘要

We have employed in parallel the Catalyst HypoGen pharmacophore modeling approach and the variable selection k-nearest neighbor quantitative structure-activity relationship (kNN QSAR) method to model a diverse data set of p38 mitogen-activated protein (MAP) kinase inhibitors. The HypoGen pharmacophore model, developed from a novel automated training set selection protocol, identified chemical functional features that were characteristic of the active compounds and differentiated the active from the inactive inhibitors. The kNN QSAR modeling employed topological descriptors and afforded predictive QSAR models with consistently high values of both leave-one-out cross-validated R~2 for the training set and predictive R~2 for the test set. The results of both modeling approaches were sensitive to the selection of the training and test sets used for model development and validation. The resulting Catalyst pharmacophore and kNN QSAR models can be used concurrently for rapid virtual screening of chemical databases to identify novel p38 MAP kinase inhibitors.
机译:我们并行采用了Catalyst HypoGen药效团建模方法和变量选择k最近邻定量结构-活性关系(kNN QSAR)方法来建模p38促分裂原活化蛋白(MAP)激酶抑制剂的多种数据集。 HypoGen药效团模型是从一种新型的自动训练集选择方案中开发出来的,可鉴定出活性化合物特征的化学功能特征,并将活性剂与非活性抑制剂区分开来。 kNN QSAR建模使用了拓扑描述符,并提供了预测性QSAR模型,该模型具有训练集的留一法制交叉验证R〜2和测试集的预测R〜2始终很高的值。两种建模方法的结果对用于模型开发和验证的训练集和测试集的选择都很敏感。所得的Catalyst药效团和kNN QSAR模型可同时用于化学数据库的快速虚拟筛选,以鉴定新型的p38 MAP激酶抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号